Swagat Seva' service introduced at Mangaluru International Airport

Bengaluru, Jun 24: About 8,48,203 students will appear in the Secondary School Leaving Certificate (SSLC) examination tomorrow, i.e., June 24, said Karnataka Health Minister B Sriramulu on Wednesday.

Students have been advised to report to the examination centre three-hour before the commencement of the examination i.e., at 07:30 am. The examination will commence at 10:30 am.

Early entry to the centres will also help maintain social distancing that is very much essential during the pandemic, minister for primary and secondary education S Suresh Kumar said.

"SSLC exams to take place tomorrow. About 8,48,203 students will write the exam. Social distancing needs to be followed and the mask should be used. Minister of Education and I have already held a lot of meetings. Students from containment zones will be carefully handled," said Sriramulu.

Commenting upon the situation arising in the state due to COVID-19, Sriramulu said, "There is a panel of experts to decide about lockdown. There has been an opinion that the COVID-19 test should be increased. Workers, traders, and others should be categorised in 15 categories and tests must be conducted," he added.

Sriramulu further said that there will be a meeting of task force on the coming Monday.

"All the issues will be brought to the notice of the Chief Minister at the task force meeting, then CM will take a call on what needs to be done," he said.

Meanwhile, Suresh Kumar, Minister of Education inspected the schools and places where SSLC exams will be held.

Earlier Karnataka Education Minister S Suresh Kumar had announced that SSLC examinations, which were stayed in view of the coronavirus pandemic, will be conducted 'between June 25 and July 4' in the state.

According to the Union Health Ministry, Karnataka has 9,721 COVID-19 cases including 150 fatalities.

Mangaluru, Apr 18: Sauharda Forum in Moodbidri has placed a food-counter stand near Krishnakatte in Moodbidri here to feed the hungry during the lockdown.

Due to strict implementation of lockdown to prevent the spread of COVID-19, shops and hotels have remained closed since last one month posing a huge difficulty for many.

Stranded migrant labourers and others can collect water bottles, fruits, biscuits, and other eatables free of cost by the people at the stand.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.